Search Count: 15
 |
Tmprss2 Crystal Structure Following Acylation By Ucsf_157
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.07 Å Release Date: 2024-12-25 Classification: HYDROLASE Ligands: CIT, EDO, VU4, UNX |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-12-25
Ligands: CIT, EDO, VU4, UNX
 |
Tmprss2 Complexed With The Noncovalent Inhibitor 6-Amidino-2-Napthol
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.19 Å Release Date: 2024-02-07 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: TAM, UNX, EDO, 7R8, PEG, CIT, PG4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-02-07
Ligands: TAM, UNX, EDO, 7R8, PEG, CIT, PG4
 |
High Resolution Tmprss2 Structure Following Acylation By Nafamostat
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2024-01-31 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: EDO, UNX, GBS, CIT, CA, PG4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-01-31
Ligands: EDO, UNX, GBS, CIT, CA, PG4
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-07-05 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U0R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-07-05
Ligands: U0R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TKX |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TKX
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TNI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TNI
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1J |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1J
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U26 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U26
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2B |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2B
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2I |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2I
 |
Sars-Cov-2 Spike Glycoprotein:Fab 5A6 Complex I
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2021-05-26
Ligands: NAG
 |
Sars-Cov-2 Spike Glycoprotein:Fab 3D11 Complex
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY
Release Date: 2021-05-26
 |
Sars-Cov-2 Spike:5A6 Fab Complex I Focused Refinement
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2021-05-26
Ligands: NAG
 |
Sars-Cov-2 Spike:Fab 3D11 Complex Focused Refinement
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2021-05-26 Classification: VIRAL PROTEIN Ligands: NAG |
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: ELECTRON MICROSCOPY
Release Date: 2021-05-26
Ligands: NAG